The effectiveness and value of midomafetamine-assisted psychotherapy for posttraumatic stress disorder

J Manag Care Spec Pharm. 2024 Oct;30(10):1191-1195. doi: 10.18553/jmcp.2024.30.10.1191.
No abstract available

Publication types

  • Letter

MeSH terms

  • Humans
  • Psychotherapy* / methods
  • Serotonin and Noradrenaline Reuptake Inhibitors / therapeutic use
  • Stress Disorders, Post-Traumatic* / therapy
  • Treatment Outcome

Substances

  • Serotonin and Noradrenaline Reuptake Inhibitors